---
title: "Regencell Bioscience Holdings Limited (RGC.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/RGC.US.md"
symbol: "RGC.US"
name: "Regencell Bioscience Holdings Limited"
industry: "制药"
---

# Regencell Bioscience Holdings Limited (RGC.US)

| Item | Detail |
|------|--------|
| Industry | 制药 |
| Location | 美股市场 |
| Website | [www.regencellbioscience.com](https://www.regencellbioscience.com) |

## Company Profile

Regencell Bioscience Holdings Limited 是一家在香港运营的传统中医（TCM）生物科技公司。它专注于中医的研究、开发和商业化，主要用于治疗神经认知障碍和退行性疾病，特别是注意力缺陷多动障碍和自闭症谱系障碍。该公司成立于 2014 年，总部位于香港铜锣湾

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4616.24 | 230/257 | - | - | - |
| PB | 3404.25 | 193/257 | 1727.56 | 1114.84 | 147.06 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/RGC.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/RGC.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/RGC.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
